Related: The Role of GLP-1s in Modern Weight Loss Strategies Understanding GLP-1s and their role in weight loss GLP-1s are a class of medications initially developed to treat type 2 diabetes
Marra, F., Gastaldelli, A., Svegliati Baroni, G., Tell, G
However, to harness these benefits effectively, careful attention must be given to dosage, baseline Se levels, and individual metabolic variations to avoid potential toxicity
Major Findings: Developed LY3437943 (retatrutide), a novel triple agonist targeting the GLP-1, GIP, and glucagon receptors
The anti-obesity market in India is currently valued at US$165-million and is expected to reach US$880-million by 2030, according to research from Pharmarack, a health tech and insights network of leading pharmaceutical companies